Keona Health - Company News

Axios: Keona Health raises $7M In Series A-1 Funding Round

Written by Stephen Dean | Aug 24, 2023 2:08:09 PM

Chapel Hill, N.C. - We are thrilled to announce that Keona Health has successfully raised $7 million in a Series A-1 funding round, as recently reported by Axios.

Read the full press release on Axios: "Exclusive: Keona Health hauls in $7 million" (https://www.axios.com/pro/health-tech-deals/2023/08/24/keona-health-7-million)

The funding round was spearheaded by Riverside Acceleration Capital (RAC), Riverside Company's growth capital arm. This collaboration with Riverside has been ongoing for three years, further solidifying our partnership.

Our CEO, Oakkar Oakkar, shared with Axios that despite being in the early stages, Keona Health is on track to become cash flow positive within the next year. Our vision is clear: to fund our own growth moving forward.

Our flagship product, the CareDesk platform, is a health care customer relationship management (CRM) system designed to simplify patient access to doctors' offices, from scheduling to telephone triage. With features like dynamic branching, integration of patient 360 databases, and clinically safe automation, we've empowered client organizations to double their provider and patient panel sizes without the need for additional hires.

Moreover, our AI-guided call support and digital self-scheduling features have significantly reduced call volumes and increased online bookings for our clients.

Looking ahead, Keona Health is gearing up for an exciting journey. We are approximately nine months away from achieving cash flow break-even. The fresh funds will primarily be directed towards enhancing our sales and marketing efforts and integrating more electronic health records (EHRs) into our platform.

As the health care landscape evolves, with primary and specialty care physician practices consolidating at an unprecedented rate, Keona Health is poised to offer solutions that streamline patient access and communication.

For more details on this development and other insights, read the full article on Axios.